Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lu Wei

Showing results (561-570 of 573) with videos related to

Pageof 58
Sort By:
Science Translational Medicine|April 22, 2026
Diabetes-induced TREM2-endothelial cell signaling impairs ischemic vascular repairNaseeb Kaur Malhi, Yingjun Luo, Muxi Chen, et al.
Plant Biotechnology Journal|August 3, 2021
The genome of Cymbidium sinense revealed the evolution of orchid traitsFeng-Xi Yang, Jie Gao, Yong-Lu Wei, et al.
Frontiers in Pharmacology|September 1, 2022
The Role and Therapeutic Potential of Macropinocytosis in CancerZejing Qiu, Wencheng Liu, Qianru Zhu, et al.
Journal of Cancer|September 14, 2017
A <i>BAP1</i> Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type <i>BAP1</i>Yu-Zheng Ge, Lu-Wei Xu, Chang-Cheng Zhou, et al.
Oncotarget|August 25, 2018
Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of RELBPo-Hao Feng, Chih-Teng Yu, Kuan-Yuan Chen, et al.
Oncotarget|February 28, 2018
S100A9<sup>+</sup> MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of <i>RELB</i>Po-Hao Feng, Chih-Teng Yu, Kuan-Yuan Chen, et al.
The Journal of Sexual Medicine|May 29, 2009
IN-1130, a novel transforming growth factor-beta type I receptor kinase (activin receptor-like kinase 5) inhibitor, promotes regression of fibrotic plaque and corrects penile curvature in a rat model of Peyronie's diseaseJi-Kan Ryu, Shuguang Piao, Hwa-Yean Shin, et al.
Medicine|April 24, 2015
Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma: A STROBE-Compliant Observational StudyYu-Zheng Ge, Lu-Wei Xu, Zheng Xu, et al.
Journal of Cancer Research and Clinical Oncology|January 31, 2015
A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinomaYu-Zheng Ge, Ran Wu, Hui Xin, et al.
Immunity|August 25, 2023
Lymphatic endothelial transcription factor Tbx1 promotes an immunosuppressive microenvironment to facilitate post-myocardial infarction repairWenfeng Wang, Xiao Li, Xiaoning Ding, et al.
Pageof 58

Showing results (561-570 of 573) with videos related to

Sort By:
Pageof 58
Science Translational Medicine|April 22, 2026
Diabetes-induced TREM2-endothelial cell signaling impairs ischemic vascular repairNaseeb Kaur Malhi, Yingjun Luo, Muxi Chen, et al.
Plant Biotechnology Journal|August 3, 2021
The genome of Cymbidium sinense revealed the evolution of orchid traitsFeng-Xi Yang, Jie Gao, Yong-Lu Wei, et al.
Frontiers in Pharmacology|September 1, 2022
The Role and Therapeutic Potential of Macropinocytosis in CancerZejing Qiu, Wencheng Liu, Qianru Zhu, et al.
Journal of Cancer|September 14, 2017
A <i>BAP1</i> Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type <i>BAP1</i>Yu-Zheng Ge, Lu-Wei Xu, Chang-Cheng Zhou, et al.
Oncotarget|August 25, 2018
Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of RELBPo-Hao Feng, Chih-Teng Yu, Kuan-Yuan Chen, et al.
Oncotarget|February 28, 2018
S100A9<sup>+</sup> MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of <i>RELB</i>Po-Hao Feng, Chih-Teng Yu, Kuan-Yuan Chen, et al.
The Journal of Sexual Medicine|May 29, 2009
IN-1130, a novel transforming growth factor-beta type I receptor kinase (activin receptor-like kinase 5) inhibitor, promotes regression of fibrotic plaque and corrects penile curvature in a rat model of Peyronie's diseaseJi-Kan Ryu, Shuguang Piao, Hwa-Yean Shin, et al.
Medicine|April 24, 2015
Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma: A STROBE-Compliant Observational StudyYu-Zheng Ge, Lu-Wei Xu, Zheng Xu, et al.
Journal of Cancer Research and Clinical Oncology|January 31, 2015
A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinomaYu-Zheng Ge, Ran Wu, Hui Xin, et al.
Immunity|August 25, 2023
Lymphatic endothelial transcription factor Tbx1 promotes an immunosuppressive microenvironment to facilitate post-myocardial infarction repairWenfeng Wang, Xiao Li, Xiaoning Ding, et al.
Pageof 58